- Home
- KMDA vs RYAM Comparison
KMDA vs RYAM Comparison
Compare KMDA & RYAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- RYAM
- Stock Information
- Founded
- KMDA 1990
- RYAM 1926
- Country
- KMDA Israel
- RYAM United States
- Employees
- KMDA N/A
- RYAM N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- RYAM Paper
- Sector
- KMDA Health Care
- RYAM Basic Materials
- Exchange
- KMDA Nasdaq
- RYAM Nasdaq
- Market Cap
- KMDA 442.1M
- RYAM 495.7M
- IPO Year
- KMDA N/A
- RYAM N/A
- Fundamental
- Price
- KMDA $7.46
- RYAM $7.39
- Analyst Decision
- KMDA Strong Buy
- RYAM Buy
- Analyst Count
- KMDA 2
- RYAM 1
- Target Price
- KMDA $14.50
- RYAM $12.00
- AVG Volume (30 Days)
- KMDA 346.0K
- RYAM 383.7K
- Earning Date
- KMDA 03-05-2025
- RYAM 03-05-2025
- Dividend Yield
- KMDA N/A
- RYAM N/A
- EPS Growth
- KMDA 124.29
- RYAM N/A
- EPS
- KMDA 0.27
- RYAM N/A
- Revenue
- KMDA $158,380,000.00
- RYAM $1,630,290,000.00
- Revenue This Year
- KMDA $15.37
- RYAM $0.83
- Revenue Next Year
- KMDA $8.58
- RYAM $4.22
- P/E Ratio
- KMDA $28.13
- RYAM N/A
- Revenue Growth
- KMDA 4.52
- RYAM N/A
- 52 Week Low
- KMDA $4.74
- RYAM $3.15
- 52 Week High
- KMDA $9.15
- RYAM $10.28
- Technical
- Relative Strength Index (RSI)
- KMDA 52.89
- RYAM 45.95
- Support Level
- KMDA $7.51
- RYAM $6.93
- Resistance Level
- KMDA $8.35
- RYAM $7.41
- Average True Range (ATR)
- KMDA 0.41
- RYAM 0.30
- MACD
- KMDA -0.02
- RYAM -0.01
- Stochastic Oscillator
- KMDA 33.20
- RYAM 28.98
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About RYAM Rayonier Advanced Materials Inc.
Rayonier Advanced Materials Inc manufactures high-purity cellulose derived from wood. Also known as cellulose specialties, the company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, High-Yield Pulp, and Corporate and Other. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of revenue from the United States.